Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SG005
- Development stage
- Preclinical
- Lead developer
- Ionis Pharmaceuticals
- Modality
- Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
SG005 is an antisense oligonucleotide (ASO) therapeutic candidate being developed by Shenji Changhua for the treatment of Amyotrophic Lateral Sclerosis (ALS). It is specifically designed to target the FUS (Fused in Sarcoma) gene transcript. In patients with FUS-mutated ALS, the FUS protein mislocalizes and forms toxic aggregates in motor neurons; SG005 aims to reduce the expression of this protein by modulating or degrading the FUS mRNA. This approach is intended to mitigate the neurotoxicity associated with FUS proteinopathy. The drug is currently in preclinical development.
02
Targets
FUS (Fused in sarcoma)
Beyond the preview
Go deeper on SG005.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SG005.